Breakthrough diabetes drug has researchers excited

Font Size:

An international study, led by Monash University, has uncovered a drug that could treat obesity, diabetes and loss of muscle mass.

With type 2 diabetes costing the Australian healthcare system more than $6 billion annually and affecting more than 1.5 million Australians, researchers are excited but cautious about the possibilities of the discovery.

An international research team led by Monash University, the Garvan Institute of Medical Research and The Baker Heart and Diabetes Institute has established that an experimental drug for obesity-related metabolic diseases could soon be tested in humans.

The study, published in the journal Nature, indicates that a compound called IC7Fc could improve glucose metabolism and prevent weight gain, enabling it to be an effective treatment for conditions including diabetes, obesity and loss of muscle mass.

The study suggests that IC7Fc could provide a welcome relief for disease sufferers, with no reported side effects in preliminary experiments.

Led by Professor Mark Febbraio, of the Monash Institute of Pharmaceutical Sciences, the 13-year study has confirmed that the protein is safe in several preclinical models. 

“This is the first time that we have demonstrated pharmacological evidence that we could treat obesity, type 2 diabetes, muscle loss and a loss of bone density with a single drug,” he said. “These ageing-related diseases have a devastating impact on sufferers and their families, while putting stress on the Australian healthcare system.”

Researchers have shown that IC7Fc improves glucose tolerance and hyperglycemia, and prevents weight gain and liver steatosis in mice.

The compound’s ability to induce muscle hypertrophy – an increase in the size of skeletal muscle through a growth in size of component cells – is important since increased muscle mass reduces the risk of type 2 diabetes.

Prof. Febbraio says there are currently no drugs on the market that have these multiple, positive benefits on overall health and metabolism.

“Type 2 diabetes costs the Australian healthcare system more than $6 billion annually and affects more than 1.5 million Australians,” he said.

“Despite the presence of a number of well-established drug classes for treating type 2 diabetes, there is still a significant unmet need for a drug that halts, or reverses, disease progression.

“A drug such as the IC7Fc could not only treat diabetes but could be harnessed to treat muscle mass loss, regulate food intake and frailty as well.”

IC7Fc has passed preclinical hurdles and is poised to enter phase one human clinical trials.

Do you suffer from type 2 diabetes? Could this development assist your condition?

If you enjoy our content, don’t keep it to yourself. Share our free eNews with your friends and encourage them to sign up.

Join YourLifeChoices today
and get this free eBook!

Join
By joining YourLifeChoices you consent that you have read and agree to our Terms & Conditions and Privacy Policy

RELATED LINKS

Study discovers that ‘yoyo dieting’ could be good for you

Repeatedly losing and regaining weight may lead to lower body fat percentages.

Onion and garlic found to reduce your risk of cancer

Consumption of onion and garlic more than once per day reduced the risk of breast cancer by

Government spends more on health but out-of-pocket costs spiralling

Government spends $7485 per person on health costs, but out-of-pocket costs a concern.

Written by Janelle Ward

3 Comments

Total Comments: 3
  1. 0
    0

    “…there is still a significant unmet need for a drug that halts, or reverses, disease progression.”…It’s all band-aids but, no cure in sight.

  2. 0
    0

    If I could reverse diabetes and weight with no side effects all with one drug, I would be pleased.

  3. 0
    0

    … Diabetes 2 can be reversed – also weight loss …….. follow the plan by
    Dr. Michael Mosley ………… it works! 🙂


FACEBOOK COMMENTS



SPONSORED LINKS

continue reading

Health Insurance

Your health insurance is about to go up. Again.

Do you feel like the cost of your health insurance is always going up? You’re not wrong. Premiums are about...

Finance

Private health rebate levels are dropping, what does that mean?

We are all used to private health insurance rebates on 1 April every year, but this year the rebates will...

Health news

Doctors call for convicted child killer Kathleen Folbigg's release

A group of 90 expert scientists and doctors is calling for convicted child killer Kathleen Folbigg to be pardoned in...

Lifestyle

Adorable celebrity pets

Just like the rest of us, Hollywood's A-listers are pretty obsessed with their pets, especially when it comes to sharing...

Health news

Who needs a colonoscopy most? Ensuring those at risk head the queue

Professor Jon Emery Mary was 55 when she started having on and off tummy pains, and noticed she needed to...

Health & Ageing

What stress does to your skin, hair and nails

Stress can be an all-consuming beast. Not only does it overwhelm your brain, but it can have a physical impact,...

Property

Multi-generational family living grows, forcing design changes

The trend towards multi-generational living, accelerated by the COVID-19 pandemic, is producing fresh approaches to Australian housing. Urban designer Craig...

Seniors Finance

Your retirement 'pay cheque'

Nothing beats the reassurance of knowing there's money coming in each month. Then retirement happens and, suddenly, it's up to...

LOADING MORE ARTICLE...